Clinical Trial Update: A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects [Phase 2]

View source ↗

Summary

A randomized Phase II trial evaluating the safety and neutralizing activity of CL184 in combination with a rabies vaccine, compared with HRIG or placebo given w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• CL184 (CL184)
• HRIG (human rabies immune globulin)
• Rabies vaccine (rabies vaccine)

Snippet

Sponsor: Crucell Holland BV | Conditions: Rabies | Phase 2 | Status: COMPLETED